Data or Dollars
In our continuing quest to educate we thought it best to provide some perspective on the difference between drugs and devices when it comes to investing. We felt this was timely as recently we have seen more money flow into the CGM wannabe arena. Now in the interest of fairness we shall not provide the names of the companies which received money, nor will we embarrass the fools who invested in these companies.
When it comes to CGM it’s about time to acknowledge some facts other than Dexcom and Abbott owning this market.
1. Developing any new CGM . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.